Commentaryβ blockers in heart failure
References (12)
- et al.
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Lancet
(1993) - et al.
Myocardial viability testing and impact of revascularization on prognosis of patients with coronary artery disease and left ventricular dysfunction: a metanalysis
J Am Con Cardiol
(2002) - et al.
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
N Engl J Med
(1996) What type of beta blocker should be used to treat chronic heart failure
Circulation
(2000)- et al.
Myocardial gene expression in dilated cardiomyopathy treated with beta blocking agents
N Engl J Med
(2002) Effect of metoprolol CR/XL in chronic heart failure
Lancet
(1999)
There are more references available in the full text version of this article.
Cited by (55)
Antiarrhythmic Agents: General Uses
2022, Small Animal Critical Care MedicineAntiarrhythmic agents
2014, Small Animal Critical Care Medicine, Second EditionAntiarrhythmic drugs and strategies
2013, Drugs for the Heart: Expert Consult - Online and PrintAntagonism of the Sympathetic Nervous System in Heart Failure
2010, Heart Failure: A Companion to Braunwald's Heart Disease Expert ConsultAntiarrhythmic Agents
2009, Small Animal Critical Care MedicineAntiarrhythmic Drugs and Strategies
2008, Drugs for the Heart: Expert Consult - Online and Print
Copyright © 2003 Elsevier Ltd. All rights reserved.